Search Results - "Valencia, Marta"

Refine Results
  1. 1
  2. 2
  3. 3

    Letter: Albumin—Does formulation matter? Authors' reply by Leache, Leire, Gutiérrez‐Valencia, Marta, Saiz, Luis Carlos, Uriz, Juan, Bolado, Federico, García‐Erce, José Antonio, Cantarelli, Lorenzo, Erviti, Juan

    Published in Alimentary pharmacology & therapeutics (01-06-2023)
    “…LINKED CONTENT This article is linked to Leache et al papers. To view these articles, visit https://doi.org/10.1111/apt.17344 and…”
    Get full text
    Journal Article
  4. 4

    Meta‐analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis by Leache, Leire, Gutiérrez‐Valencia, Marta, Saiz, Luis Carlos, Uriz, Juan, Bolado, Federico, García‐Erce, José Antonio, Cantarelli, Lorenzo, Erviti, Juan

    Published in Alimentary pharmacology & therapeutics (01-03-2023)
    “…Summary Introduction Albumin is used in multiple situations in patients with cirrhosis, but the evidence of its benefit is not always clear. The aim was to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Efficacy and safety of N-acetylcysteine for preventing post-intravenous contrast acute kidney injury in patients with kidney impairment: a systematic review and meta-analysis by Maestro, Claudia, Leache, Leire, Gutiérrez-Valencia, Marta, Saiz, Luis Carlos, Gómez, Helena, Bacaicoa, Maria Carmen, Erviti, Juan

    Published in European radiology (01-09-2023)
    “…Objectives N-Acetylcysteine (NAC) may confer protection against post-contrast acute kidney injury (PC-AKI), although evidence is sparse and conflicting. The…”
    Get full text
    Journal Article
  9. 9

    Incidence of Attention Deficit Hyperactivity Disorder (ADHD) Diagnoses in Navarre (Spain) from 2003 to 2019 by Leache, Leire, Arrizibita, Olast, Gutiérrez-Valencia, Marta, Saiz, Luis Carlos, Erviti, Juan, Librero, Julián

    “…(1) Background: Attention deficit hyperactivity disorder (ADHD) constitutes one of the leading mental health and behavioral disorders in childhood and…”
    Get full text
    Journal Article
  10. 10

    COVID‐19 infection and complications according to ABO blood group in the elderly: A population‐based subcohort and meta‐analysis by Leache, Leire, Gutiérrez‐Valencia, Marta, Enguita‐Germán, Mónica, Librero, Julián, Gorricho, Javier, Jericó, Carlos, García‐Erce, Jose Antonio

    Published in Vox sanguinis (01-10-2022)
    “…Background and Objectives It is reported that ABO antibodies have a role in COVID‐19 infection and severity; however, ABO antibody titres vary with advanced…”
    Get full text
    Journal Article
  11. 11

    Optipharm: Enhancing pharmacological management skills in healthcare students for geriatric care through gamified e-learning by Roncal-Belzunce, Victoria, Gutiérrez-Valencia, Marta, Echeverría-Beistegui, Icíar, Martínez-Velilla, Nicolás

    “…•Optipharm is a gamified tool to enhance students’ polypharmacy management skills.•Optipharm integrates gamification into pharmacological management education,…”
    Get full text
    Journal Article
  12. 12

    Systematic review and meta-analysis on the effectiveness of multidisciplinary interventions to address polypharmacy in community-dwelling older adults by Roncal-Belzunce, Victoria, Gutiérrez-Valencia, Marta, Leache, Leire, Saiz, Luis Carlos, Bell, J Simon, Erviti, Juan, Martínez-Velilla, Nicolás

    Published in Ageing research reviews (01-07-2024)
    “…Interventions to address polypharmacy in community-dwelling older adults often focus on medication-related outcomes. The aim was to explore the impact of…”
    Get full text
    Journal Article
  13. 13

    Restoring Study PRGF: a randomized clinical trial on plasma rich in growth factors for knee osteoarthritis by Saiz, Luis Carlos, Erviti, Juan, Leache, Leire, Gutiérrez-Valencia, Marta

    “…A randomized clinical trial assessing plasma rich in growth factors (PRGF) versus hyaluronic acid for knee osteoarthritis was published in 2012 (sponsor trial…”
    Get full text
    Journal Article
  14. 14

    Role of Pharmacogenomics in the Efficacy and Safety of Thiopurines in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis by Gutiérrez-Valencia, Marta, Leache, Leire, Saiz, Luis Carlos, Beloqui, Juan J., Barajas, Miguel, Vicuña, Miren, Erviti, Juan

    Published in Journal of clinical gastroenterology (01-08-2023)
    “…Thiopurines' toxicity often leads to dose reduction or discontinuation. This systematic review aims to synthesize the evidence on the effect of genotype-based…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Pharmacotherapy for hypertension-induced left ventricular hypertrophy by Leache, Leire, Gutiérrez-Valencia, Marta, Finizola, Rosa M, Infante, Elizabeth, Finizola, Bartolome, Pardo Pardo, Jordi, Flores, Yris, Granero, Ricardo, Arai, Kaduo J

    Published in Cochrane database of systematic reviews (10-10-2021)
    “…Hypertension is the leading preventable risk factor for cardiovascular disease and premature death worldwide. One of the clinical effects of hypertension is…”
    Get more information
    Journal Article
  18. 18

    Prevalence of polypharmacy and associated factors in older adults in Spain: Data from the National Health Survey 2017 by Gutiérrez-Valencia, Marta, Aldaz Herce, Pablo, Lacalle-Fabo, Esther, Contreras Escámez, Beatriz, Cedeno-Veloz, Bernardo, Martínez-Velilla, Nicolás

    Published in Medicina clinica (16-08-2019)
    “…to estimate the prevalence of polypharmacy and hyperpolypharmacy in non-institutionalised older adults in Spain and assess the associated factors. a…”
    Get more information
    Journal Article
  19. 19

    Medicine optimization strategy in an acute geriatric unit: The pharmacist in the geriatric team by Gutiérrez‐Valencia, Marta, Izquierdo, Mikel, Beobide‐Telleria, Idoia, Ferro‐Uriguen, Alexander, Alonso‐Renedo, Javier, Casas‐Herrero, Álvaro, Martínez‐Velilla, Nicolás

    Published in Geriatrics & gerontology international (01-06-2019)
    “…Aim Older patients admitted to acute geriatric units (AGU) frequently use many medications and are particularly vulnerable to adverse drug events, so specific…”
    Get full text
    Journal Article
  20. 20

    Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data by Erviti, Juan, Wright, James, Bassett, Ken, Ben-Eltriki, Mohamed, Jauca, Ciprian, Saiz, Luis Carlos, Leache, Leire, Gutiérrez-Valencia, Marta, Perry, Thomas L

    Published in BMJ open (30-12-2022)
    “…The FOURIER trial showed a benefit of the PCSK9 inhibitor evolocumab over placebo with respect to cardiovascular outcomes in patients with cardiovascular…”
    Get full text
    Journal Article